TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT06664983 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06664983
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2025-10-21
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.